Leo B Silenieks Selected Research

Leo B Silenieks Research Topics

5	Obesity 01/2020 - 04/2012
3	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 01/2022 - 01/2020
3	Tobacco Use Disorder (Nicotine Dependence) 01/2019 - 04/2012
2	Gambling (Pathological Gambling) 01/2021 - 01/2018
1	Major Depressive Disorder (Major Depressive Disorders) 01/2021
1	Polydipsia 01/2020
1	Weight Loss (Weight Reduction) 07/2016
1	Binge-Eating Disorder (Binge Eating Disorder) 07/2016
1	Feeding and Eating Disorders (Eating Disorder) 07/2016
1	Body Weight (Weight, Body) 02/2015
1	Body Weight Changes 02/2015
1	Psychomotor Agitation (Akathisia) 01/2013

5	lorcaserinIBA 01/2020 - 04/2012
5	5-HT2C Serotonin ReceptorIBA 01/2020 - 04/2012
3	Adenosine Monophosphate (AMP)IBA 01/2022 - 01/2020
3	Atomoxetine Hydrochloride (Strattera)FDA LinkGeneric 01/2022 - 01/2020
2	Amphetamine (Amfetamine)FDA LinkGeneric 01/2022 - 01/2020
2	Methylphenidate (Ritalin)FDA LinkGeneric 01/2022 - 01/2020
1	Hallucinogens (Psychedelics)IBA 01/2021
1	Psilocybin (Psilocibin)IBA 01/2021
1	Ketamine FDA LinkGeneric 01/2021
1	Nicotine FDA Link 01/2020
1	Serotonin 5-HT2 Receptor AgonistsIBA 01/2020
1	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 01/2019
1	Varenicline (Chantix)FDA Link 01/2019
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2018
1	Ro 631908IBA 01/2018
1	Dizocilpine Maleate (Dizocilpine)IBA 01/2018
1	SteamIBA 01/2013
1	lavender oilIBA 01/2013

1	Drug Therapy (Chemotherapy) 01/2022
1	Therapeutics 06/2012